LIVE
Home
Politics
Business
Opinion
Technology
Lifestyle
Entertainment
Video
J&J's new ketamine-like depression drug Spravato off to 'very, very strong start,' company says
Business
April 16, 2019
This article is being updated.
Previous article: Zoom raises IPO price range and could now be worth almost $9 billion in debut
Prev
Next article: Zoom raises IPO price range, could now be worth almost $9 billion, showing investors crave profits
Next
via
CNBC
April 16th 2019
MixedTimes.com
Business
J&J's new ketamine-like depression drug Spravato off to 'very, very strong start,' company says
Home
Politics
Business
Opinion
Technology
Lifestyle
Entertainment
Video